Author:
Crook Angela M., ,Turkova Anna,Musiime Victor,Bwakura-Dangarembizi Mutsa,Bakeera-Kitaka Sabrina,Nahirya-Ntege Patricia,Thomason Margaret,Mugyenyi Peter,Musoke Philippa,Kekitiinwa Adeodata,Munderi Paula,Nathoo Kusum,Prendergast Andrew J.,Walker A. Sarah,Gibb Diana M.
Funder
UK Medical Research Council (MRC) and Department for International Development (DFID)
Wellcome Trust
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2015.
2. World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2014.
3. Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001270.
4. Mu W, Zhao Y, Sun X, Ma Y, Yu L, Liu X, et al. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study. AIDS Care. 2014;26(9):1127–35.
5. Bakeera-Kitaka S, Conesa-Botella A, Dhabangi A, Maganda A, Kekitiinwa A, Colebunders R, et al. Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis. 2011;15(8):1082–6.